0.09
+3.74%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mauna Kea Technologies
Its shares trade on Euronext Paris under the ticker ALMKT.PA. It has been listed since 5 July 2011. In the fiscal year to 31 December 2025, it reported revenue of €8.2m and net income of €10.8m. At that date it held total assets of €13.4m and shareholders' equity of −€4.8m.
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2011-07-05. The firm focuses on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product is Cellvizio, a confocal laser endomicroscopy platform using microprobes and needles. This technological platform enables to view tissues at cellular level, in real time, during standard procedure. Cellvizio can be used in gastroenterology, pulmonology, or urology. The firm markets its technological platform in more than 40 countries, including the United States, Europe, Japan, China, South Korea as well as several Latin American countries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 5 Jul 2011
- Employees
- 72
- Website
- maunakeatech.com ↗
Leadership
Pay as last reported
- Mr. Alexandre LoiseauChairman of the Board, Chief Executive Officer, since 2011€252,094
- Mr. Come de La Tour Du PinChief Financial Officer
- Dr. Claire BiotIndependent Director€15,000
- Mr. Christopher McfaddenIndependent Director, since 2014€40,000
- Ms. Molly O'NeillIndependent Director€40,000
- Ms. Jacquelien Ten DamIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mauna Kea Technologies SAS is known for its innovative and cutting-edge technology, positioning the company as a leader in the industry. This technology provides reliable and accurate results, giving it a competitive advantage in the market.
- The company holds a strong portfolio of intellectual property, including patents and trademarks, which protect its innovative technology and give it exclusive rights in the market. This serves as a barrier to entry for potential competitors.
- Mauna Kea Technologies SAS has a strong global presence with its products being sold in multiple countries. This allows the company to reach a larger customer base and explore new market opportunities.
- The company has a dedicated research and development team that consistently works on improving and developing new technologies. This ensures that Mauna Kea Technologies SAS stays ahead of its competitors and continues to offer innovative solutions in the field.
Weaknesses
- The production costs for Mauna Kea Technologies SAS are relatively high due to the complexity and precision required for its technology. This can impact the company's profitability and pricing strategies, potentially limiting its market share.
- The company relies on a few key suppliers for critical components of its products. Any disruption in the supply chain or issues with these suppliers could lead to delays in production and delivery, affecting customer satisfaction and overall performance.
Opportunities
- There is a growing global market for medical and diagnostic technologies. Mauna Kea Technologies SAS can leverage its global presence to further expand into emerging markets, offering its innovative solutions to a wider range of customers.
- Forming strategic partnerships and collaborations with healthcare institutions, research organizations, and other industry players can provide Mauna Kea Technologies SAS with access to new resources, expertise, and market insights. This can lead to mutually beneficial collaborations and accelerate company growth.
Threats
- The industry in which Mauna Kea Technologies SAS operates is highly competitive, with numerous players offering similar products and technologies. This creates pricing pressures and the need for continuous innovation to maintain market share.
- The medical and diagnostic technology industry is subject to strict regulatory requirements and approval processes. Compliance with these regulations can be time-consuming and costly, potentially delaying product launches and limiting market access.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.